Cargando…
GEMIN4, a potential therapeutic targets for patients with basal-like subtype breast cancer
BACKGROUND: Basal-like breast cancer (BLBC) takes up about 10–20% of all breast cancer(BC), what’s more, BLBC has the lowest survival rate among all BC subtypes because of lacks of efficient treatment methods. We aimed to explore the molecules that can be used as diagnostic maker for BLBC at early s...
Autores principales: | Wu, Liang, Zhang, Yue, Zheng, Chunlei, Zhao, Fuqiang, Lin, Yan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10386636/ https://www.ncbi.nlm.nih.gov/pubmed/37507701 http://dx.doi.org/10.1186/s12905-023-02547-1 |
Ejemplares similares
-
GEMINs: potential therapeutic targets for spinal muscular atrophy?
por: Borg, Rebecca, et al.
Publicado: (2014) -
Transcription factor E2F8 is a therapeutic target in the basal-like subtype of breast cancer
por: Zheng, Jing, et al.
Publicado: (2023) -
Feline mammary basal-like adenocarcinomas: a potential model for human triple-negative breast cancer (TNBC) with basal-like subtype
por: Wiese, David A, et al.
Publicado: (2013) -
The rise of gemination in Celtic
por: Stifter, David
Publicado: (2023) -
Genetic variants in the MicroRNA biosynthetic pathway Gemin3 and Gemin4 are associated with a risk of cancer: a meta-analysis
por: Zhu, Wenbo, et al.
Publicado: (2016)